FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 57 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $771,000 | -38.0% | 231,800 | -43.4% | 0.00% | -42.9% |
Q3 2019 | $1,244,000 | +21.0% | 409,500 | -5.3% | 0.01% | +16.7% |
Q2 2019 | $1,028,000 | -42.0% | 432,200 | -8.5% | 0.01% | -40.0% |
Q1 2019 | $1,771,000 | -3.3% | 472,300 | -7.5% | 0.01% | -9.1% |
Q4 2018 | $1,832,000 | -48.2% | 510,500 | -17.3% | 0.01% | -42.1% |
Q3 2018 | $3,538,000 | +1921.7% | 617,500 | +1664.3% | 0.02% | +1800.0% |
Q2 2018 | $175,000 | +5.4% | 35,000 | +7.7% | 0.00% | 0.0% |
Q1 2018 | $166,000 | -12.2% | 32,500 | +3.2% | 0.00% | 0.0% |
Q4 2017 | $189,000 | +200.0% | 31,500 | +173.9% | 0.00% | – |
Q3 2017 | $63,000 | – | 11,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 4,781,708 | $28,738,000 | 4.90% |
DSC Advisors, L.P. | 1,187,604 | $7,138,000 | 4.14% |
Opaleye Management Inc. | 960,000 | $5,769,000 | 1.85% |
DAFNA Capital Management LLC | 352,741 | $2,120,000 | 1.14% |
Vivo Capital, LLC | 855,000 | $5,139,000 | 1.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 382,838 | $2,301,000 | 0.81% |
SENZAR ASSET MANAGEMENT, LLC | 377,397 | $2,268,000 | 0.58% |
Sio Capital Management, LLC | 131,200 | $789,000 | 0.44% |
Perceptive Advisors | 1,117,324 | $6,715,000 | 0.22% |
Tekla Capital Management LLC | 930,398 | $5,592,000 | 0.22% |